Featured Research

from universities, journals, and other organizations

Insomnia prevalent among cancer patients who receive chemotherapy

Date:
November 23, 2009
Source:
University of Rochester Medical Center
Summary:
In a study of cancer patients and survivors, three-quarters report having insomnia or sleep problems following chemotherapy.

Three quarters of cancer patients and survivors treated with chemotherapy suffer insomnia or sleep disorders that often become chronic conditions, hindering patients' ability to fully recover, according to scientists at the University of Rochester Medical Center.

Related Articles


A study of 823 cancer patients showed they experienced sleep troubles at nearly three times the rate of the general population. The problem was more prevalent in younger patients and those with lung and breast cancers, according to the paper published online in the Journal of Clinical Oncology.

"These numbers are very high and something we can't ignore," said Oxana Palesh, Ph.D., M.P.H., research assistant professor of Radiation Oncology at the Medical Center's James P. Wilmot Cancer Center and lead author of the paper. "The good news is that insomnia is a very treatable problem that can be addressed quickly so it doesn't compound other symptoms."

Palesh reviewed data on patients who received chemotherapy between 1997 and 1999 at private practice medical oncology groups who were part of the National Cancer Institute's Community Clinical Oncology Program (CCOP.)

Patients answered questionnaires after their first two chemotherapy treatments. Responses to sleep-related questions showed that 37 percent of participants suffered from insomnia symptoms and another 43 percent had insomnia syndrome, as categorized by the Hamilton Depression Inventory, a widely used measure for symptoms of depression. These patients had difficulty falling asleep and staying asleep at least three days per week.

The challenge is that once people experience sleep problems and related fatigue, they begin taking naps and going to bed earlier, which perpetuates the problem and is counter-productive to getting restorative sleep at night, Palesh said.

Sleep problems are generally combined with patients complaints of fatigue and depression however, it has not been studied to determine the causes and impact on patients' quality of life.

Authors of the National Cancer Institute-funded study recognize many factors can cause sleep difficulties, such as depression and anxiety, but note the duration of treatment and extended sleep disruptions can contribute to other health problems.

Others who contributed to the study include Gary Morrow, Ph.D., M.S., Joseph Roscoe, Ph.D., Karen Mustian, Ph.D., M.P.H., Charles Heckler, Ph.D., and Michelle Janelsins, Ph.D., of Rochester's CCOP, along with Thomas Roth, Ph.D., of Henry Ford Hospital, Josee Savard, Ph.D., of Universite Laval, and Sonia Ancoli-Israel, Ph.D., of University of California-San Diego, and Jason Purnell, Ph.D., M.P.H., of Washington University.


Story Source:

The above story is based on materials provided by University of Rochester Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Rochester Medical Center. "Insomnia prevalent among cancer patients who receive chemotherapy." ScienceDaily. ScienceDaily, 23 November 2009. <www.sciencedaily.com/releases/2009/11/091123171240.htm>.
University of Rochester Medical Center. (2009, November 23). Insomnia prevalent among cancer patients who receive chemotherapy. ScienceDaily. Retrieved March 28, 2015 from www.sciencedaily.com/releases/2009/11/091123171240.htm
University of Rochester Medical Center. "Insomnia prevalent among cancer patients who receive chemotherapy." ScienceDaily. www.sciencedaily.com/releases/2009/11/091123171240.htm (accessed March 28, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, March 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins